Ronny W. Renfurm
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Iptacopan in IgA Nephropathy - Final 24-Month Data.
Journal: The New England journal of medicine
Published: March 30, 2026
Iptacopan in Patients With IgA Nephropathy From East Asia.
Journal: Kidney international reports
Published: August 19, 2025
Corrigendum to "Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy" [Volume 10, Issue 1, January 2025, Pages 217-226].
Journal: Kidney international reports
Published: April 30, 2025
Atrasentan in Patients with IgA Nephropathy.
Journal: The New England journal of medicine
Published: October 26, 2024
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy.
Journal: The New England journal of medicine
Published: October 25, 2024
Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy.
Journal: Kidney international reports
Published: July 15, 2024
Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial).
Journal: BMJ open
Published: April 06, 2023
Vascular Adhesion Protein-1 Is Associated With Acute Kidney Injury in High-Risk Patients After Cardiac Surgery.
Journal: Anesthesia and analgesia
Published: November 20, 2019
The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients.
Journal: The Journal of thoracic and cardiovascular surgery
Published: June 26, 2019
Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema.
Journal: International journal of retina and vitreous
Published: April 01, 2019
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial.
Journal: The lancet. Diabetes & endocrinology
Published: July 16, 2018
Last Updated: 09/26/2026